Live from the NIH registry
Studies recruiting near Huntington right now
Top 25 of 58 recruiting studies, sorted by proximity — each links to its official registry page
Dinutuximab With Chemotherapy, Surgery and Stem Cell Transplantation for the Treatment of Children With Newly Diagnosed High Risk Neuroblastoma
Ganglioneuroblastoma, Nodular, Neuroblastoma
Phase 3
Interventional 478 participants sought
Edwards Comprehensive Cancer Center — Huntington, West Virginia (0.8 mi)
· Sponsor: National Cancer Institute (NCI)
A Study to Assess the Efficacy and Safety of Induction Therapy With Afimkibart (RO7790121) in Participants With Moderately to Severely Active Crohn's Disease
Moderately to Severely Active Crohns Disease
Phase 3
Interventional 425 participants sought
University Physicians and Surgeons Inc, dba Marshall Health — Huntington, West Virginia (0.8 mi)
· Sponsor: Hoffmann-La Roche
Assessing Benefits and Harms of Cannabis/Cannabinoid Use Among Cancer Patients Treated in Community Oncology Clinics
Breast Carcinoma, Colorectal Carcinoma
N/A
Observational 2,000 participants sought
Edwards Comprehensive Cancer Center — Huntington, West Virginia (0.8 mi)
· Sponsor: Wake Forest University Health Sciences
Targeted Treatment for Metastatic Prostate Cancer, The PREDICT Trial
Castration-Resistant Prostate Carcinoma, Stage IVB Prostate Cancer AJCC v8
Phase 2
Interventional 474 participants sought
Edwards Comprehensive Cancer Center — Huntington, West Virginia (0.8 mi)
· Sponsor: Alliance for Clinical Trials in Oncology
Evaluation of Tirzepatide as an Adjunct to Buprenorphine for the Treatment of Opioid Use Disorder
Opioid Use Disorder, Opioid Use Disorder, Moderate
Phase 2
Interventional 310 participants sought
Marshall Health — Huntington, West Virginia (0.8 mi)
· Sponsor: T. John Winhusen, PhD
RSSearch Patient Registry-Long Term Study of Use of SRS/SBRT
Neoplasms, Arteriovenous Malformation of Central Nervous System
N/A
Observational 50,000 participants sought
St. Mary's Medical Center — Huntington, West Virginia (0.8 mi)
· Sponsor: The Radiosurgery Society
De-Escalation of Breast Radiation Trial for Hormone Sensitive, HER-2 Negative, Oncotype Recurrence Score Less Than or Equal to 18 Breast Cancer (DEBRA)
Stage I Breast Cancer
Phase 3
Interventional 1,670 participants sought
Edwards Comprehensive Cancer Center — Huntington, West Virginia (0.8 mi)
· Sponsor: NRG Oncology
DeciPHer-ILD: A Real-world Patient Registry in Group 3 Pulmonary Hypertension Associated With Interstitial Lung Disease (PH-ILD)
Pulmonary Hypertension Due to Lung Diseases and Hypoxia, Pulmonary Hypertension
N/A
Observational 900 participants sought
Marshall Health — Huntington, West Virginia (0.8 mi)
· Sponsor: United Therapeutics
Cognitive Training for Cancer Related Cognitive Impairment in Breast Cancer Survivors
Breast Cancer, Cognitive Impairments
N/A
Interventional 386 participants sought
Edwards Comprehensive Cancer Center — Huntington, West Virginia (0.8 mi)
· Sponsor: NRG Oncology
Identifying Findings on Brain Scans That Could Help Make Better Predictions About Brain Cancer Progression, The GABLE Trial
Glioblastoma, IDH-Wildtype
Phase 2
Interventional 100 participants sought
Edwards Comprehensive Cancer Center — Huntington, West Virginia (0.8 mi)
· Sponsor: ECOG-ACRIN Cancer Research Group
A Study of Combination Chemotherapy for Patients With Newly Diagnosed DAWT and Relapsed FHWT
Anaplastic Kidney Wilms Tumor, Recurrent Kidney Wilms Tumor
Phase 2
Interventional 256 participants sought
Edwards Comprehensive Cancer Center — Huntington, West Virginia (0.8 mi)
· Sponsor: Children's Oncology Group
Testing the Addition of a Type of Drug Called Immunotherapy to the Usual Chemotherapy Treatment for Non-small Cell Lung Cancer, an ALCHEMIST Treatment Trial (Chemo-IO [ACCIO])
Lung Non-Small Cell Carcinoma, Lung Non-Small Cell Squamous Carcinoma
Phase 3
Interventional 1,210 participants sought
Edwards Comprehensive Cancer Center — Huntington, West Virginia (0.8 mi)
· Sponsor: National Cancer Institute (NCI)
ShortStop-HER2: 12 Months vs. 6 Months of HER2-targeted Medications for People With HER2+ Breast Cancer Who Had a Pathologic Complete Response After Chemotherapy Plus Trastuzumab
Anatomic Stage I Breast Cancer AJCC v8, Anatomic Stage II Breast Cancer AJCC v8
Phase 3
Interventional 1,524 participants sought
Edwards Comprehensive Cancer Center — Huntington, West Virginia (0.8 mi)
· Sponsor: Alliance for Clinical Trials in Oncology
Lung-MAP: A Master Screening Protocol for Previously-Treated Non-Small Cell Lung Cancer
Previously Treated Non-Small Cell Lung Cancer
Phase 2, Phase 3
Interventional 10,000 participants sought
Edwards Comprehensive Cancer Center — Huntington, West Virginia (0.8 mi)
· Sponsor: SWOG Cancer Research Network
Chemotherapy Combined With Immunotherapy Versus Immunotherapy Alone for Older Adults With Stage IIIB-IV Lung Cancer, The ACHIEVE Trial
Advanced Lung Non-Small Cell Carcinoma, Stage IIIB Lung Cancer AJCC v8
Phase 3
Interventional 304 participants sought
Edwards Comprehensive Cancer Center — Huntington, West Virginia (0.8 mi)
· Sponsor: National Cancer Institute (NCI)
Collecting Blood Samples From Patients With and Without Cancer to Evaluate Tests for Early Cancer Detection
Multiple conditions
N/A
Observational 2,000 participants sought
Edwards Comprehensive Cancer Center — Huntington, West Virginia (0.8 mi)
· Sponsor: Alliance for Clinical Trials in Oncology
Testing the Addition of Stereotactic Radiation Therapy With Immune Therapy for the Treatment of Patients With Unresectable or Metastatic Renal Cell Cancer, SAMURAI Trial
Metastatic Renal Cell Carcinoma, Stage III Renal Cell Cancer AJCC v8
Phase 2
Interventional 240 participants sought
Edwards Comprehensive Cancer Center — Huntington, West Virginia (0.8 mi)
· Sponsor: NRG Oncology
A Study of Intismeran Autogene (V940) Plus Pembrolizumab (MK-3475) Versus Placebo Plus Pembrolizumab in Participants With Non-small Cell Lung Cancer (V940-002)
Non-small Cell Lung Cancer
Phase 3
Interventional 868 participants sought
Edwards Comprehensive Cancer Center ( Site 4015) — Huntington, West Virginia (0.8 mi)
· Sponsor: Merck Sharp & Dohme LLC
Qudexy XR for the Prevention of Migraine in Children 6 to 11 Years Old
Migraine Disorders
Phase 4
Interventional 132 participants sought
Upsher-Smith Clinical Trial Site #9 — Huntington, West Virginia (0.8 mi)
· Sponsor: Upsher-Smith Laboratories
A Long-Term Study of Elafibranor in Adult Participants With Primary Biliary Cholangitis
Primary Biliary Cholangitis (PBC)
Phase 3
Interventional 276 participants sought
University Physicians and Surgeons Inc, dba Marshall Health — Huntington, West Virginia (0.8 mi)
· Sponsor: Ipsen
Effect of Labetalol, Atenolol, and Nifedipine on Maternal Hemodynamics Measured by ICG in Early Pregnancy
Systolic Hypertension, Pregnancy Related
N/A
Observational 60 participants sought
Maternal Hypertension Center at Cabell Huntington Hospital — Huntington, West Virginia (0.8 mi)
· Sponsor: Marshall University
A Phase II Nationwide, Fully Decentralized, Telemedicine Study of Pemigatinib in Adult Patients With Advanced or Metastatic Pancreatic Cancer With FGFR Genetic Alterations
Advanced Pancreatic Carcinoma, Metastatic Pancreatic Carcinoma
Phase 2
Interventional 40 participants sought
Ohio State University Telemedicine — Huntington, West Virginia (0.8 mi)
· Sponsor: Sameek Roychowdhury
Testing Shorter Duration Radiation Therapy Versus the Usual Radiation Therapy in Patients With High Risk Prostate Cancer
Prostate Adenocarcinoma, Stage III Prostate Cancer AJCC v8
Phase 3
Interventional 1,209 participants sought
Edwards Comprehensive Cancer Center — Huntington, West Virginia (0.8 mi)
· Sponsor: NRG Oncology
A Study to Compare Standard Therapy to Treat Hodgkin Lymphoma to the Use of Two Drugs, Brentuximab Vedotin and Nivolumab
Lugano Classification Limited Stage Hodgkin Lymphoma AJCC v8
Phase 3
Interventional 1,875 participants sought
Edwards Comprehensive Cancer Center — Huntington, West Virginia (0.8 mi)
· Sponsor: National Cancer Institute (NCI)
SuperSaturated Oxygen Comprehensive Observational Registry
STEMI - ST Elevation Myocardial Infarction, AMI
N/A
Observational 1,000 participants sought
St Mary's Medical Center — Huntington, West Virginia (0.8 mi)
· Sponsor: TherOx